Literature DB >> 24847182

A SPECIAL MEETING REVIEW EDITION: Highlights in Crohn's Disease and Ulcerative Colitis: Digestive Disease Week 2012 May 19-22, 2012 • San Diego, CaliforniaSpecial Reporting on:• Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active UC: PURSUIT-SC• The Future of IBD Therapy: Individualized and Optimized Therapy and Novel Mechanisms• Infliximab Concentration and Clinical Outcome in Patients with UC• Vedolizumab Induction Therapy for UC: Results of GEMINI I, A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase III Trial• Novel Infliximab and Antibody-to-lnfliximab Assays Are Predictive of Disease Activity in Patients with CD• Accelerated Step-Care Therapy with Early Azathioprine Versus Conventional Step-Care Therapy in CD• PIANO: A 1,000-Patient Prospective Registry of Pregnancy Outcomes in Women with IBD Exposed to Immunomodulators and Biologic TherapyPLUS Meeting Abstract Summaries With Expert Commentary by: William J. Sandborn, MDChief of the Division of Gastroenterology Director of the UCSD IBD Center UC San Diego Health System La Jolla, California.

.   

Abstract

Entities:  

Year:  2012        PMID： 24847182      PMCID： PMC4024246     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  15 in total

1.  Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.

Authors:  Brian G Feagan; Gordon R Greenberg; Gary Wild; Richard N Fedorak; Pierre Paré; John W D McDonald; Rejean Dubé; Albert Cohen; A Hillary Steinhart; Steven Landau; Rasha A Aguzzi; Irving H Fox; Margaret K Vandervoort
Journal:  N Engl J Med       Date:  2005-06-16       Impact factor: 91.245

2.  Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.

Authors:  Elana A Maser; Renata Villela; Mark S Silverberg; Gordon R Greenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2006-08-22       Impact factor: 11.382

3.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.

Authors:  Jean Frédéric Colombel; Paul Rutgeerts; Walter Reinisch; Dirk Esser; Yanxin Wang; Yinghua Lang; Colleen W Marano; Richard Strauss; Björn J Oddens; Brian G Feagan; Stephen B Hanauer; Gary R Lichtenstein; Daniel Present; Bruce E Sands; William J Sandborn
Journal:  Gastroenterology       Date:  2011-06-30       Impact factor: 22.682

4.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

5.  Infliximab for induction and maintenance therapy for ulcerative colitis.

Authors:  Paul Rutgeerts; William J Sandborn; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Suzanne Travers; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel Present; Bruce E Sands; Jean Frédéric Colombel
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

6.  Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.

Authors:  Casper Steenholdt; Klaus Bendtzen; Jørn Brynskov; Ole Østergaard Thomsen; Mark Andrew Ainsworth
Journal:  Scand J Gastroenterol       Date:  2010-11-18       Impact factor: 2.423

7.  Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.

Authors:  David J Shealy; Ann Cai; Kim Staquet; Audrey Baker; Eilyn R Lacy; Laura Johns; Omid Vafa; George Gunn; Susan Tam; Sarah Sague; Dana Wang; Mike Brigham-Burke; Paul Dalmonte; Eva Emmell; Bill Pikounis; Peter J Bugelski; Honghui Zhou; Bernard J Scallon; Jill Giles-Komar
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

8.  The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.

Authors:  Dulce Soler; Tobias Chapman; Li-Li Yang; Tim Wyant; Robert Egan; Eric R Fedyk
Journal:  J Pharmacol Exp Ther       Date:  2009-06-09       Impact factor: 4.030

9.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325

10.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health.

Authors:  Laurent Peyrin-Biroulet; Alarcos Cieza; William J Sandborn; Michaela Coenen; Yehuda Chowers; Toshifumi Hibi; Nenad Kostanjsek; Gerold Stucki; Jean-Frédéric Colombel
Journal:  Gut       Date:  2011-06-05       Impact factor: 23.059
View more
  5 in total

Review 1.  A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy.

Authors:  Sherman Picardo; Cynthia H Seow
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

Review 2.  IBD: reproductive health, pregnancy and lactation.

Authors:  Philip Hendy; Georgina Chadwick; Ailsa Hart
Journal:  Frontline Gastroenterol       Date:  2014-04-15

Review 3.  Management of Inflammatory Bowel Disease During Pregnancy.

Authors:  Ariella Bar-Gil Shitrit; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

Review 4.  Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management.

Authors:  Pegah Hosseini-Carroll; Monica Mutyala; Abhishek Seth; Shaheen Nageeb; Demiana Soliman; Moheb Boktor; Ankur Sheth; Jonathon Chapman; James Morris; Paul Jordan; Kenneth Manas; Felix Becker; Jonathan Steven Alexander
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

5.  New and emerging treatments for ulcerative colitis: a focus on vedolizumab.

Authors:  Tamsin Gledhill; Keith Bodger
Journal:  Biologics       Date:  2013-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.